These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

570 related items for PubMed ID: 16957572

  • 1. Relationship between antihypertensive drug therapy and cognitive function in elderly hypertensive patients with memory complaints.
    Hanon O, Pequignot R, Seux ML, Lenoir H, Bune A, Rigaud AS, Forette F, Girerd X.
    J Hypertens; 2006 Oct; 24(10):2101-7. PubMed ID: 16957572
    [Abstract] [Full Text] [Related]

  • 2. Effects of hypertension therapy based on eprosartan on systolic arterial blood pressure and cognitive function: primary results of the Observational Study on Cognitive function And Systolic Blood Pressure Reduction open-label study.
    Hanon O, Berrou JP, Negre-Pages L, Goch JH, Nádházi Z, Petrella R, Sedefdjian A, Sévenier F, Shlyakhto EV, Pathak A.
    J Hypertens; 2008 Aug; 26(8):1642-50. PubMed ID: 18622244
    [Abstract] [Full Text] [Related]

  • 3. Evolution of blood pressure in patients with Alzheimer's disease: a one year survey of a French Cohort (REAL.FR).
    Hanon O, Latour F, Seux ML, Lenoir H, Forette F, Rigaud AS, REAL.FR Group.
    J Nutr Health Aging; 2005 Aug; 9(2):106-11. PubMed ID: 15791354
    [Abstract] [Full Text] [Related]

  • 4. [Isolated systolic hypertension and cognitive function in the aged. Experience of the Syst-Eur study].
    Seux ML, Thijs L, Forette F.
    Arch Mal Coeur Vaiss; 1997 Aug; 90(8):1169-72. PubMed ID: 9404430
    [Abstract] [Full Text] [Related]

  • 5. Prevalence of non-dementing cognitive disturbances and their association with vascular risk factors in an elderly population.
    Prencipe M, Santini M, Casini AR, Pezzella FR, Scaldaferri N, Culasso F.
    J Neurol; 2003 Aug; 250(8):907-12. PubMed ID: 12928907
    [Abstract] [Full Text] [Related]

  • 6. Conversion of mild cognitive impairment to dementia in elderly subjects: a preliminary study in a memory and cognitive disorder unit.
    Maioli F, Coveri M, Pagni P, Chiandetti C, Marchetti C, Ciarrocchi R, Ruggero C, Nativio V, Onesti A, D'Anastasio C, Pedone V.
    Arch Gerontol Geriatr; 2007 Aug; 44 Suppl 1():233-41. PubMed ID: 17317458
    [Abstract] [Full Text] [Related]

  • 7. Conversion of amnestic Mild Cognitive Impairment to dementia of Alzheimer type is independent to memory deterioration.
    Rozzini L, Chilovi BV, Conti M, Bertoletti E, Delrio I, Trabucchi M, Padovani A.
    Int J Geriatr Psychiatry; 2007 Dec; 22(12):1217-22. PubMed ID: 17562522
    [Abstract] [Full Text] [Related]

  • 8. Observational Study on Cognitive function And systolic blood pressure Reduction (OSCAR): preliminary analysis of 6-month data from > 10,000 patients and review of the literature.
    Shlyakhto E.
    Curr Med Res Opin; 2007 Nov; 23 Suppl 5():S13-8. PubMed ID: 18093409
    [Abstract] [Full Text] [Related]

  • 9. Outcomes of a computer-based cognitive rehabilitation program on Alzheimer's disease patients compared with those on patients affected by mild cognitive impairment.
    Cipriani G, Bianchetti A, Trabucchi M.
    Arch Gerontol Geriatr; 2006 Nov; 43(3):327-35. PubMed ID: 16451811
    [Abstract] [Full Text] [Related]

  • 10. Angiotensin converting enzyme (ACE) inhibitors modulate the rate of progression of amnestic mild cognitive impairment.
    Rozzini L, Chilovi BV, Bertoletti E, Conti M, Del Rio I, Trabucchi M, Padovani A.
    Int J Geriatr Psychiatry; 2006 Jun; 21(6):550-5. PubMed ID: 16642542
    [Abstract] [Full Text] [Related]

  • 11. Rationale, design and methods of the OSCAR study: observational study on cognitive function and systolic blood pressure reduction in hypertensive patients.
    Pathak A, Hanon O, Negre-Pages L, Sevenier F, OSCAR investigators.
    Fundam Clin Pharmacol; 2007 Apr; 21(2):199-205. PubMed ID: 17391293
    [Abstract] [Full Text] [Related]

  • 12. Nonepisodic memory deficits in amnestic MCI.
    Economou A, Papageorgiou SG, Karageorgiou C, Vassilopoulos D.
    Cogn Behav Neurol; 2007 Jun; 20(2):99-106. PubMed ID: 17558253
    [Abstract] [Full Text] [Related]

  • 13. Relationship between arterial stiffness and cognitive function in elderly subjects with complaints of memory loss.
    Hanon O, Haulon S, Lenoir H, Seux ML, Rigaud AS, Safar M, Girerd X, Forette F.
    Stroke; 2005 Oct; 36(10):2193-7. PubMed ID: 16151027
    [Abstract] [Full Text] [Related]

  • 14. Apolipoprotein E genotypes in hospitalized elderly patients with vascular dementia.
    Orsitto G, Seripa D, Panza F, Franceschi M, Cascavilla L, Placentino G, Matera MG, Paris F, Capurso C, Solfrizzi V, Dallapiccola B, Pilotto A.
    Dement Geriatr Cogn Disord; 2007 Oct; 23(5):327-33. PubMed ID: 17374951
    [Abstract] [Full Text] [Related]

  • 15. Effects of cholinesterase inhibitors appear greater in patients on established antihypertensive therapy.
    Rozzini L, Vicini Chilovi B, Bellelli G, Bertoletti E, Trabucchi M, Padovani A.
    Int J Geriatr Psychiatry; 2005 Jun; 20(6):547-51. PubMed ID: 15920713
    [Abstract] [Full Text] [Related]

  • 16. Influence of cognitive impairment and comorbidity on disability in hospitalized elderly patients.
    Orsitto G, Cascavilla L, Franceschi M, Aloia RM, Greco A, Paris F, Seripa D, Pilotto A.
    J Nutr Health Aging; 2005 Jun; 9(3):194-8. PubMed ID: 15864400
    [Abstract] [Full Text] [Related]

  • 17. Mild cognitive impairment: epidemiology and dementia risk in an elderly Italian population.
    Ravaglia G, Forti P, Montesi F, Lucicesare A, Pisacane N, Rietti E, Dalmonte E, Bianchin M, Mecocci P.
    J Am Geriatr Soc; 2008 Jan; 56(1):51-8. PubMed ID: 18028343
    [Abstract] [Full Text] [Related]

  • 18. Demented versus non-demented very old inpatients: the same comorbidities but poorer functional and nutritional status.
    Zekry D, Herrmann FR, Grandjean R, Meynet MP, Michel JP, Gold G, Krause KH.
    Age Ageing; 2008 Jan; 37(1):83-9. PubMed ID: 17971391
    [Abstract] [Full Text] [Related]

  • 19. Mild cognitive impairment: an opportunity to identify patients at high risk for progression to Alzheimer's disease.
    Levey A, Lah J, Goldstein F, Steenland K, Bliwise D.
    Clin Ther; 2006 Jul; 28(7):991-1001. PubMed ID: 16990077
    [Abstract] [Full Text] [Related]

  • 20. Anosognosia in Alzheimer's disease: association with patient characteristics, psychiatric symptoms and cognitive deficits.
    Kashiwa Y, Kitabayashi Y, Narumoto J, Nakamura K, Ueda H, Fukui K.
    Psychiatry Clin Neurosci; 2005 Dec; 59(6):697-704. PubMed ID: 16401246
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.